In this study, we attempted to measure three serum biomarkers of ovarian cancer, CA125, transthyretin, and apolipoprotein A1, using a multiplex bead-based immunoassay system, and evaluated the combined effect of the three biomarkers for the diagnosis of ovarian cancer compared with those of the individual markers alone. This evidence concerns the gene TTR and ovarian cancer.